Genome-wide analysis of gene expression in neuroblastomas detected by mass screening

Neuroblastoma (NB) is the most common extracranial solid tumor of childhood and the third most common pediatric cancer. Although numerous factors including patient age, disease stage and genetic abnormalities have been shown to be predictive of outcome, the mechanisms responsible for the highly vari...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer letters 2005-07, Vol.225 (1), p.111-120
Hauptverfasser: Krause, Alexander, Combaret, Valérie, Iacono, Isabelle, Lacroix, Bruno, Compagnon, Christelle, Bergeron, Christophe, Valsesia-Wittmann, Sandrine, Leissner, Philippe, Mougin, Bruno, Puisieux, Alain
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 120
container_issue 1
container_start_page 111
container_title Cancer letters
container_volume 225
creator Krause, Alexander
Combaret, Valérie
Iacono, Isabelle
Lacroix, Bruno
Compagnon, Christelle
Bergeron, Christophe
Valsesia-Wittmann, Sandrine
Leissner, Philippe
Mougin, Bruno
Puisieux, Alain
description Neuroblastoma (NB) is the most common extracranial solid tumor of childhood and the third most common pediatric cancer. Although numerous factors including patient age, disease stage and genetic abnormalities have been shown to be predictive of outcome, the mechanisms responsible for the highly variable clinical behavior of this tumor remain largely unknown. In order to gain new insights into the biology of this tumor, we performed microarray analysis and compared the gene expression patterns of NB detected by mass screening, characterized by highly probable spontaneous regression, versus stage 4 NB with poor prognosis. The bioinformatics analysis revealed a set of 19 discriminatory genes that may play a significant role in the natural progression of the disease. Validation of these results and further mechanistic studies would shed new light on the biology of tumor progression, and provide new tools to predict clinical outcome in children with NB.
doi_str_mv 10.1016/j.canlet.2004.10.035
format Article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_00157917v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0304383504008444</els_id><sourcerecordid>3241566971</sourcerecordid><originalsourceid>FETCH-LOGICAL-c565t-7e9aa8d98073427e773823ee7eba5648aab2e4b26f0e5d3d2dff7f2ffb3c7c183</originalsourceid><addsrcrecordid>eNqFkV1rFDEUhoNY7Fr9ByIBQfBitvmYTDI3QinaFhZ6U69DJjlTs8wkazLTuv_eDLMoeKFXIS_P-eA8CL2jZEsJbS73W2vCANOWEVKXaEu4eIE2VElWyVaRl2hDOKkrrrg4R69z3hNCRC3FK3RORcuYavgGPdxAiCNUz94BNsEMx-wzjj1-hAAYfh4S5OxjwD7gAHOK3WDyFEeTsYMJ7AQOd0dc_hlnmwCCD49v0FlvhgxvT-8F-vb1y8P1bbW7v7m7vtpVVjRiqiS0xihXdpW8ZhKk5IpxAAmdEU2tjOkY1B1regLCccdc38ue9X3HrbRU8Qv0ae373Qz6kPxo0lFH4_Xt1U4vGSFUyJbKJ1rYjyt7SPHHDHnSo88WhsEEiHPWjVRSKP5_kLY1rVuyTP_wF7iPcyonLIwggstldqHqlbIp5pyg_70oJXoRqfd6FakXkUtaRJay96fmczeC-1N0MleAzysA5cBPHpLO1kOw4HwqWrSL_t8TfgFMx7Aq</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1505371579</pqid></control><display><type>article</type><title>Genome-wide analysis of gene expression in neuroblastomas detected by mass screening</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Krause, Alexander ; Combaret, Valérie ; Iacono, Isabelle ; Lacroix, Bruno ; Compagnon, Christelle ; Bergeron, Christophe ; Valsesia-Wittmann, Sandrine ; Leissner, Philippe ; Mougin, Bruno ; Puisieux, Alain</creator><creatorcontrib>Krause, Alexander ; Combaret, Valérie ; Iacono, Isabelle ; Lacroix, Bruno ; Compagnon, Christelle ; Bergeron, Christophe ; Valsesia-Wittmann, Sandrine ; Leissner, Philippe ; Mougin, Bruno ; Puisieux, Alain</creatorcontrib><description>Neuroblastoma (NB) is the most common extracranial solid tumor of childhood and the third most common pediatric cancer. Although numerous factors including patient age, disease stage and genetic abnormalities have been shown to be predictive of outcome, the mechanisms responsible for the highly variable clinical behavior of this tumor remain largely unknown. In order to gain new insights into the biology of this tumor, we performed microarray analysis and compared the gene expression patterns of NB detected by mass screening, characterized by highly probable spontaneous regression, versus stage 4 NB with poor prognosis. The bioinformatics analysis revealed a set of 19 discriminatory genes that may play a significant role in the natural progression of the disease. Validation of these results and further mechanistic studies would shed new light on the biology of tumor progression, and provide new tools to predict clinical outcome in children with NB.</description><identifier>ISSN: 0304-3835</identifier><identifier>EISSN: 1872-7980</identifier><identifier>DOI: 10.1016/j.canlet.2004.10.035</identifier><identifier>PMID: 15922863</identifier><language>eng</language><publisher>Ireland: Elsevier Ireland Ltd</publisher><subject>Adrenal glands ; Age ; Algorithms ; Cancer ; Child, Preschool ; Computational Biology ; Disease Progression ; Enzymes ; Expression profiling ; Female ; Gene expression ; Gene Expression Profiling ; Genome ; Genomes ; Humans ; Immunochemistry ; Infant ; Life Sciences ; Male ; Mass Screening ; Mortality ; Neuroblastoma ; Neuroblastoma - genetics ; Oligonucleotide Array Sequence Analysis ; Outcome prediction ; Proteins ; Software ; Tumors</subject><ispartof>Cancer letters, 2005-07, Vol.225 (1), p.111-120</ispartof><rights>2005 Elsevier Ireland Ltd</rights><rights>Copyright Elsevier Limited Jul 8, 2005</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c565t-7e9aa8d98073427e773823ee7eba5648aab2e4b26f0e5d3d2dff7f2ffb3c7c183</citedby><cites>FETCH-LOGICAL-c565t-7e9aa8d98073427e773823ee7eba5648aab2e4b26f0e5d3d2dff7f2ffb3c7c183</cites><orcidid>0000-0001-9151-6261 ; 0000-0002-9938-3798</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.canlet.2004.10.035$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15922863$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-00157917$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Krause, Alexander</creatorcontrib><creatorcontrib>Combaret, Valérie</creatorcontrib><creatorcontrib>Iacono, Isabelle</creatorcontrib><creatorcontrib>Lacroix, Bruno</creatorcontrib><creatorcontrib>Compagnon, Christelle</creatorcontrib><creatorcontrib>Bergeron, Christophe</creatorcontrib><creatorcontrib>Valsesia-Wittmann, Sandrine</creatorcontrib><creatorcontrib>Leissner, Philippe</creatorcontrib><creatorcontrib>Mougin, Bruno</creatorcontrib><creatorcontrib>Puisieux, Alain</creatorcontrib><title>Genome-wide analysis of gene expression in neuroblastomas detected by mass screening</title><title>Cancer letters</title><addtitle>Cancer Lett</addtitle><description>Neuroblastoma (NB) is the most common extracranial solid tumor of childhood and the third most common pediatric cancer. Although numerous factors including patient age, disease stage and genetic abnormalities have been shown to be predictive of outcome, the mechanisms responsible for the highly variable clinical behavior of this tumor remain largely unknown. In order to gain new insights into the biology of this tumor, we performed microarray analysis and compared the gene expression patterns of NB detected by mass screening, characterized by highly probable spontaneous regression, versus stage 4 NB with poor prognosis. The bioinformatics analysis revealed a set of 19 discriminatory genes that may play a significant role in the natural progression of the disease. Validation of these results and further mechanistic studies would shed new light on the biology of tumor progression, and provide new tools to predict clinical outcome in children with NB.</description><subject>Adrenal glands</subject><subject>Age</subject><subject>Algorithms</subject><subject>Cancer</subject><subject>Child, Preschool</subject><subject>Computational Biology</subject><subject>Disease Progression</subject><subject>Enzymes</subject><subject>Expression profiling</subject><subject>Female</subject><subject>Gene expression</subject><subject>Gene Expression Profiling</subject><subject>Genome</subject><subject>Genomes</subject><subject>Humans</subject><subject>Immunochemistry</subject><subject>Infant</subject><subject>Life Sciences</subject><subject>Male</subject><subject>Mass Screening</subject><subject>Mortality</subject><subject>Neuroblastoma</subject><subject>Neuroblastoma - genetics</subject><subject>Oligonucleotide Array Sequence Analysis</subject><subject>Outcome prediction</subject><subject>Proteins</subject><subject>Software</subject><subject>Tumors</subject><issn>0304-3835</issn><issn>1872-7980</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkV1rFDEUhoNY7Fr9ByIBQfBitvmYTDI3QinaFhZ6U69DJjlTs8wkazLTuv_eDLMoeKFXIS_P-eA8CL2jZEsJbS73W2vCANOWEVKXaEu4eIE2VElWyVaRl2hDOKkrrrg4R69z3hNCRC3FK3RORcuYavgGPdxAiCNUz94BNsEMx-wzjj1-hAAYfh4S5OxjwD7gAHOK3WDyFEeTsYMJ7AQOd0dc_hlnmwCCD49v0FlvhgxvT-8F-vb1y8P1bbW7v7m7vtpVVjRiqiS0xihXdpW8ZhKk5IpxAAmdEU2tjOkY1B1regLCccdc38ue9X3HrbRU8Qv0ae373Qz6kPxo0lFH4_Xt1U4vGSFUyJbKJ1rYjyt7SPHHDHnSo88WhsEEiHPWjVRSKP5_kLY1rVuyTP_wF7iPcyonLIwggstldqHqlbIp5pyg_70oJXoRqfd6FakXkUtaRJay96fmczeC-1N0MleAzysA5cBPHpLO1kOw4HwqWrSL_t8TfgFMx7Aq</recordid><startdate>20050708</startdate><enddate>20050708</enddate><creator>Krause, Alexander</creator><creator>Combaret, Valérie</creator><creator>Iacono, Isabelle</creator><creator>Lacroix, Bruno</creator><creator>Compagnon, Christelle</creator><creator>Bergeron, Christophe</creator><creator>Valsesia-Wittmann, Sandrine</creator><creator>Leissner, Philippe</creator><creator>Mougin, Bruno</creator><creator>Puisieux, Alain</creator><general>Elsevier Ireland Ltd</general><general>Elsevier Limited</general><general>Elsevier</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><orcidid>https://orcid.org/0000-0001-9151-6261</orcidid><orcidid>https://orcid.org/0000-0002-9938-3798</orcidid></search><sort><creationdate>20050708</creationdate><title>Genome-wide analysis of gene expression in neuroblastomas detected by mass screening</title><author>Krause, Alexander ; Combaret, Valérie ; Iacono, Isabelle ; Lacroix, Bruno ; Compagnon, Christelle ; Bergeron, Christophe ; Valsesia-Wittmann, Sandrine ; Leissner, Philippe ; Mougin, Bruno ; Puisieux, Alain</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c565t-7e9aa8d98073427e773823ee7eba5648aab2e4b26f0e5d3d2dff7f2ffb3c7c183</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adrenal glands</topic><topic>Age</topic><topic>Algorithms</topic><topic>Cancer</topic><topic>Child, Preschool</topic><topic>Computational Biology</topic><topic>Disease Progression</topic><topic>Enzymes</topic><topic>Expression profiling</topic><topic>Female</topic><topic>Gene expression</topic><topic>Gene Expression Profiling</topic><topic>Genome</topic><topic>Genomes</topic><topic>Humans</topic><topic>Immunochemistry</topic><topic>Infant</topic><topic>Life Sciences</topic><topic>Male</topic><topic>Mass Screening</topic><topic>Mortality</topic><topic>Neuroblastoma</topic><topic>Neuroblastoma - genetics</topic><topic>Oligonucleotide Array Sequence Analysis</topic><topic>Outcome prediction</topic><topic>Proteins</topic><topic>Software</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Krause, Alexander</creatorcontrib><creatorcontrib>Combaret, Valérie</creatorcontrib><creatorcontrib>Iacono, Isabelle</creatorcontrib><creatorcontrib>Lacroix, Bruno</creatorcontrib><creatorcontrib>Compagnon, Christelle</creatorcontrib><creatorcontrib>Bergeron, Christophe</creatorcontrib><creatorcontrib>Valsesia-Wittmann, Sandrine</creatorcontrib><creatorcontrib>Leissner, Philippe</creatorcontrib><creatorcontrib>Mougin, Bruno</creatorcontrib><creatorcontrib>Puisieux, Alain</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>Cancer letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Krause, Alexander</au><au>Combaret, Valérie</au><au>Iacono, Isabelle</au><au>Lacroix, Bruno</au><au>Compagnon, Christelle</au><au>Bergeron, Christophe</au><au>Valsesia-Wittmann, Sandrine</au><au>Leissner, Philippe</au><au>Mougin, Bruno</au><au>Puisieux, Alain</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Genome-wide analysis of gene expression in neuroblastomas detected by mass screening</atitle><jtitle>Cancer letters</jtitle><addtitle>Cancer Lett</addtitle><date>2005-07-08</date><risdate>2005</risdate><volume>225</volume><issue>1</issue><spage>111</spage><epage>120</epage><pages>111-120</pages><issn>0304-3835</issn><eissn>1872-7980</eissn><abstract>Neuroblastoma (NB) is the most common extracranial solid tumor of childhood and the third most common pediatric cancer. Although numerous factors including patient age, disease stage and genetic abnormalities have been shown to be predictive of outcome, the mechanisms responsible for the highly variable clinical behavior of this tumor remain largely unknown. In order to gain new insights into the biology of this tumor, we performed microarray analysis and compared the gene expression patterns of NB detected by mass screening, characterized by highly probable spontaneous regression, versus stage 4 NB with poor prognosis. The bioinformatics analysis revealed a set of 19 discriminatory genes that may play a significant role in the natural progression of the disease. Validation of these results and further mechanistic studies would shed new light on the biology of tumor progression, and provide new tools to predict clinical outcome in children with NB.</abstract><cop>Ireland</cop><pub>Elsevier Ireland Ltd</pub><pmid>15922863</pmid><doi>10.1016/j.canlet.2004.10.035</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0001-9151-6261</orcidid><orcidid>https://orcid.org/0000-0002-9938-3798</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0304-3835
ispartof Cancer letters, 2005-07, Vol.225 (1), p.111-120
issn 0304-3835
1872-7980
language eng
recordid cdi_hal_primary_oai_HAL_hal_00157917v1
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Adrenal glands
Age
Algorithms
Cancer
Child, Preschool
Computational Biology
Disease Progression
Enzymes
Expression profiling
Female
Gene expression
Gene Expression Profiling
Genome
Genomes
Humans
Immunochemistry
Infant
Life Sciences
Male
Mass Screening
Mortality
Neuroblastoma
Neuroblastoma - genetics
Oligonucleotide Array Sequence Analysis
Outcome prediction
Proteins
Software
Tumors
title Genome-wide analysis of gene expression in neuroblastomas detected by mass screening
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T07%3A07%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Genome-wide%20analysis%20of%20gene%20expression%20in%20neuroblastomas%20detected%20by%20mass%20screening&rft.jtitle=Cancer%20letters&rft.au=Krause,%20Alexander&rft.date=2005-07-08&rft.volume=225&rft.issue=1&rft.spage=111&rft.epage=120&rft.pages=111-120&rft.issn=0304-3835&rft.eissn=1872-7980&rft_id=info:doi/10.1016/j.canlet.2004.10.035&rft_dat=%3Cproquest_hal_p%3E3241566971%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1505371579&rft_id=info:pmid/15922863&rft_els_id=S0304383504008444&rfr_iscdi=true